Pharmaceutical formulation | Compound | PCR | PLS | siPLS |
---|---|---|---|---|
Founda % ± SD | ||||
Petro® tablets | PAR | 104.37 ± 1.698 | 103.78 ± 2.125 | 104.05 ± 0.982 |
CAF | 94.67 ± 2.032 | 99.31 ± 1.833 | 98.21 ± 2.063 | |
DRO | 96.85 ± 2.059 | 97.35 ± 1.268 | 103.00 ± 1.789 | |
Standard addition | PAR | 99.99 ± 1.342 | 100.51 ± 1.892 | 99.98 ± 1.698 |
CAF | 100.65 ± 1.768 | 99.18 ± 0.970 | 99.62 ± 0.589 | |
DRO | 99.50 ± 1.137 | 100.22 ± 1.660 | 100.52 ± 1.288 | |
PAP | 98.47 ± 0.686 | 99.82 ± 1.617 | 99.58 ± 1.838 | |
THEO | 97.25 ± 0.922 | 98.99 ± 1.773 | 98.06 ± 1.007 | |
HVA | 100.65 ± 1.768 | 99.98 ± 1.698 | 97.02 ± 1.917 |